YOLFTbeta
HLB Co. Ltd

HLB Co. Ltd

028300 · KQ · Industrials / Building Products & Equipment

28,550.00KRW-850.00 (-2.89%)

Price History

Full chart

Market Stats

Previous Close29,400.00
Open29,450.00
Day Range28,500.00 – 30,150.00
52-Week Range24,150.00 – 69,200.00
Volume582.76K
Market Cap3.80T
P/E (TTM)0.00
Forward P/E0.00
EPS-1,606.22
Dividend Yield0.00%
Beta0.52
50-Day Avg36,586.00
200-Day Avg45,681.25

About

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.

Company Details

  • SectorIndustrials
  • IndustryBuilding Products & Equipment
  • CEOMr. Yoon Ki Baek
  • Employees150
  • Headquarters216-53, Dangwol-ro, Ulsan, South Korea, 45011, Korea
  • Websitehttps://www.hlbbio.co.kr/

Leadership

  • Mr. Yang-Gon JinExecutive Chairman · b. 1966
  • Mr. Yoon Ki BaekCEO & Executive Director · b. 1963
  • Mr. Lim Chang YoonVice Chairman · b. 1966
  • Mr. Sung-Cheol KimHead of Bio Department · b. 1964
  • Mr. Jae-Hyung ParkExecutive Director · b. 1966

Financials

Income Statement

Currency: KRW2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.52B9.27B5.08B17.88B29.81B43.73B69.52B51.67B31.45B37.19B38.46B30.14B23.01B36.19B38.42B56.18B69.83B179.71B42.90B68.13B84.17B
Growth (%)-+42.21%-45.19%+251.96%+66.71%+46.70%+58.96%-25.67%-39.13%+18.23%+3.43%-21.64%-23.66%+57.28%+6.18%+46.22%+24.30%+157.37%-76.13%+58.80%+23.55%
Cost of Revenue5.14B7.04B4.80B13.11B23.01B37.43B55.82B42.86B26.78B29.69B32.43B25.87B20.82B29.70B34.48B45.87B48.76B113.46B43.79B56.07B56.46B
Gross Profit---------5.92B6.03B4.27B2.19B6.49B3.94B10.31B21.07B66.24B-893.51M12.05B27.71B
Gross Margin---------15.92%15.68%14.17%9.52%17.92%10.25%18.35%30.17%36.86%-2.08%17.69%32.92%
Operating Expense---------5.56B12.63B25.68B33.95B7.19B59.89B71.81B124.61B143.42B200.31B135.37B126.32B
Operating Income------2.59B--362.18M-6.60B-21.41B-31.75B-702.22M-55.95B-61.51B-103.54B-77.17B-201.20B-123.31B-98.61B
Operating Margin------3.72%--0.97%-17.15%-71.04%-138.02%-1.94%-145.63%-109.48%-148.28%-42.94%-468.99%-181.01%-117.16%
EBITDA------------------60.39B-192.53B-92.30B-222.75B
EBITDA Margin------------------33.61%-448.78%-135.49%-264.64%
Net Income----------2.93B12.64B-13.21B-16.53B25.34B-44.39B-80.09B-98.13B-78.16B-187.55B-91.98B-220.50B
Net Income Margin----------7.88%32.86%-43.85%-71.85%70.04%-115.53%-142.57%-140.53%-43.49%-437.17%-135.02%-261.96%
R&D-----191.23M1.23B-1.86B1.11B2.03B10.11B12.73B22.24B-22.59B48.42B43.87B49.15B41.23B59.95B
R&D as % of Total Revenue-----0.44%1.76%-5.92%2.99%5.28%33.55%55.33%61.46%-40.22%69.34%24.41%114.56%60.52%71.22%
Interest Expense0000000000000005.26B3.63B11.69B10.59B10.72B12.43B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.37%5.19%6.51%24.68%15.73%14.77%

Balance Sheet

Currency: KRW2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets24.76B32.27B48.05B69.70B81.48B58.11B54.25B38.24B36.10B54.25B185.17B186.71B188.19B304.04B362.61B706.48B743.69B967.27B751.72B887.42B930.18B
Total Liabilities14.99B12.84B28.68B26.38B35.02B34.80B33.06B19.64B20.60B31.23B100.52B97.96B110.95B129.36B177.72B226.73B307.73B329.33B169.48B310.85B435.76B
Total Equity9.77B19.44B19.38B40.26B39.69B23.31B19.97B18.60B16.14B23.97B84.65B88.75B77.24B174.68B184.89B479.75B435.96B637.94B523.89B576.57B418.46B
Cash4.27B9.98B17.34B941.57M3.19B1.93B3.55B1.36B1.25B10.20B4.37B9.37B7.35B30.23B40.86B220.68B99.80B195.70B108.89B93.05B40.98B
Total Debt-----------12.32B7.14B49.96B85.18B15.51B-----
Net Debt--------------45.77B----50.68B224.28B

Cash Flow

Currency: KRW2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow----303.53M728.78M---3.97B724.49M-10.15B-19.08B-29.16B-48.66B-56.51B-54.77B-61.82B-111.63B-114.31B-92.59B
Investing Cash Flow------112.88M--5.48B-55.15B-2.89B-12.98B-28.20B-26.83B-98.02B-68.50B-112.28B25.53B-74.85B-
Financing Cash Flow20.28B47.68B3.01B10.92B5.44B11.85B-7.08B18.98B48.00B18.05B30.10B79.99B86.66B341.02B1.34B267.58B-3.05B170.34B-
Capital Expenditure189.39M2.12B3.73B6.84B5.06B5.97B901.09M768.45M1.66B3.37B2.42B1.70B599.66M1.72B972.23M2.19B12.63B7.06B27.07B17.53B
Free Cash Flow---------------131.49B-60.91B-74.44B-118.69B-141.38B-110.12B
Dividends Paid-----------83.58M83.58M83.58M83.58M0----
FCF to OCF--------------232.68%111.21%120.43%106.32%123.68%118.94%
Dividend Paid to FCF---------------0.06%0.00%----

Earnings

Report DateMar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015May 13, 2016Aug 12, 2016Nov 11, 2016Mar 6, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 21, 2018May 15, 2018Aug 13, 2018Nov 14, 2018Feb 25, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 19, 2020May 8, 2020Aug 14, 2020Nov 16, 2020Feb 25, 2021May 14, 2021Aug 13, 2021Nov 15, 2021Feb 23, 2022Apr 25, 2022Jul 20, 2022Nov 14, 2022Feb 17, 2023May 15, 2023Aug 11, 2023Nov 14, 2023Mar 21, 2024May 14, 2024Aug 14, 2024Nov 12, 2024Feb 26, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Feb 24, 2026May 13, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------
EPS Actual-3.01-43.599.45-80.494.08-25.69-1.91-15.03-26.54-18.08200.28-8.24-23.21-28.21-92.93-23.94-35.76-70.23-59.95679.67-188.70-174.52349.93-115.18-742.35213.83173.14-135.67-466.1835.29-213.53-163.38-282.6287.32-507.91-147.9758.94-292.99-340.45-170.00-228.57-164.00-915.42247.23-790.7431.00-191.74-489.55-439.92-557.10-193.07-286.00-579.00
Surprise-----------------------------------------------------
Timing-----------Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap3.80T
Enterprise Value4.04T
Trailing P/E0.00
Forward P/E0.00
Price / Sales38.94
Price / Book11.02
EPS-1,606.22
Book Value2,589.64
Revenue (TTM)97.47B
Gross Profit (TTM)40.44B
EBITDA-86.97B
Profit Margin-219.08%
Operating Margin-95.63%
Return on Equity-48.50%
Return on Assets-7.05%
Shares Outstanding132.94M
Shares Float120.43M
Beta0.52
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 2, 202321:20
  • Dec 28, 20221359:1303
  • Oct 13, 20221544:1495
  • Mar 15, 20212:1
  • Jun 5, 202011:10
  • Apr 17, 20202216:2159
  • Dec 10, 20101:8
  • Jul 28, 20052532:2425
  • May 12, 20051:5
  • Sep 9, 20031:12